A Double-Blind, Placebo-Controlled, Minimized PHase IIII Study Comparing Marimastat to Placebo as Adjuvant Therapy in Pancreatic Cancer.

  • Bramhall, Simon (Principal Investigator)

Project Details

Short titleA Double-Blind, Placebo-Controlled, Minimized PHase IIII Study Comparing Marimastat to Placebo as Adjuvant Therapy in Pancreatic Cancer.
StatusFinished
Effective start/end date1/12/98 → 31/07/02

Funding

  • BRITISH BIOTECH PHARMACEUTICALS LTD